Ropes & Gray Represents Signify Health in its Sale to CVS Health
Ropes & Gray represented Signify Health in its sale to CVS Health in an all-cash transaction valued at $30.50 per share or approximately $8 billion in total consideration. CVS Health anticipates that the transaction will close in the first half of 2023. The transaction was announced on Sept. 5 in a press release.
Signify Health is a health care platform that leverages advanced analytics, technology and nationwide healthcare provider networks to create and power value-based payment programs. CVS Health is a U.S. healthcare company that owns CVS Pharmacy, CVS Caremark and Aetna, among other brands.
The Ropes & Gray team that represented Signify Health was led by private equity partner Garrett Charon, mergers & acquisitions partner Chris Comeau and mergers & acquisitions counsel Aileen Kim, and included private equity partner John Sorkin, litigation & enforcement partners David Hennes and Jonathan Klarfeld, tax partners Adam Greenwood and Alyssa Kollmeyer, benefits partner Danna Kivell, employment counsel Stephanie Bruce, health care partner Jen Romig, finance partner Arek Maczka, and IP transactions partner Violetta Kokolus.